Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere
2024
Enabling Access to Medical Innovations for all
2023
A strategic approach to snakebite community engagement
Lack of diagnostics helps fuel AMR
2022
Advancing family planning solutions in Burundi
Call for Action: High Time to Prioritise Health in the EU Artificial Intelligence Act
HAI is Hiring!
2021
Talking Medicine Pricing
Over 9 million people living with type 1 diabetes
European Commission is offering no meaningful solutions for equitable access
Clinical Trial Data and the Risk of Bias
Getting Hack to Reality
Health Action International successful recipients of core funding from the European AI Fund
2020
There is no UHC without Universal Medicines Coverage
HAI’s Great Health Hack Delivers Great Ideas for Access to Meds
What do the next five years have in store for the European Medicines Agency?
COVID-19 and Snakebite: Including the voices of our most marginalised
COVID-19 risks turning back the clock on years of essential development work
Reflections on the World Health Assembly
Europe’s Beating Cancer Plan
2019
Statement from the ACCISS Study regarding the WHO announcement of the first-ever insulin prequalification programme
Biased cancer drug trials are only good for one group…and it’s not patients
In Memory of Royjan Taylor
2018
HAI and Snakebite Programme Partner, James Ashe Antivenom Trust, Applaud Government Action on Antivenom at Bio-Ken Snakebite Symposium
2015
HSA4A Signs Partnership Agreement to Address Sexual and Reproductive Health and Rights in East Africa
2013
Conference contemplations: ‘Pharmaceuticals and global health – inequalities and innovation in the 21st century’
Despite concrete steps forward, the ENVI vote on clinical trials regulation falls short on transparency
2011